Dectin 2a, Recombinant, Mouse (CLEC6A, CLECSF10, NKCL)

Dectin-2a, also known as CLEC6A, CLECSF10, and NKCL, belongs to the C-type lectin family of transmembrane immune regulatory glycoproteins. Dectin-2a, CLEC4A/DCIR, CLEC4B/DCAR, CLEC4C/DLEC, CLEC4D/MCL, and CLEC4E/mincle constitute a subgroup of these molecules that exhibit approximately 40% aa sequence identity in their extracellular domains (ECD) and have a conserved cysteine spacing in their carbohydrate recognition domains (CRD). 1,2 Mature mouse dectin-2a consists of a short cytoplasmic tail, a transmembrane segment, and an ECD with a stalk region and one CRD. 3,4 Alternate splicing leads to partial deletion of the transmembrane segment and stalk (b isoform) or a portion of the CRD (g isoform). 4 The full length dectin-2a isoform is a 27 kD molecule that is primarily expressed on the surface of tissue macrophages and their precursors. 3-6 The CRD of dectin-2a contains an EPN motif which is characteristic of calcium-dependent mannose-binding lectins. Dectin-2a selectively interacts with high mannose structures in the Man9GlcNAc2 configuration. 7 It mediates the recognition of a variety of microorganisms, particularly the filamentous forms of yeast and fungii. 7,8 The short cytoplasmic tail does not contain signaling motifs but mediates association with the ITAM-containing Fc receptor g subunit in macrophages. 8 Ligation of dectin-2a induces tyrosine phosphorylation of the g subunit, activation of NFkB, and enhanced release of TNF-a and IL-1ra. 8 Macrophage dectin-2a is upregulated in vivo by inflammatory stimuli and UV-B irradiation. 6 It mediates the breaking of UV-induced tolerance by interacting with CD4+ CD25+ regulatory T cells which then induce dendritic cells to release IL-4, IL-10, and TGF-b. 9 Within the ECD, mouse dectin-2a shares 71% aa sequence identity with human and bovine dectin-2.\n\nSource: \nHuman CD33 signal peptide (Met 1-Ala 16), HHHHHHHA, Mouse Dectin-2a (Phe43-Leu209). A DNA sequence encoding the N-terminal polyhistidine tagged extracellular domain of mouse dectin-2a (Phe 43-Leu 209; Accession # AAF67177) (Ariizumi, K., et al., 2000 J. Biol. Chem., 275: 11957-63) was fused to the signal peptide of human CD33 at the N-terminus. The protein was expressed in a mouse myeloma cell line, NS0.\n\nMolecular Mass: \nThe recombinant mature polyhistidine tagged mouse dectin-2a, generated by the removal of the signal peptide region, is a monomeric protein. Based on N-terminal sequencing, the mature recombinant mouse dectin-2a begins with the histidine tag and has a calculated molecular mass of 20.6 kD. As a result of glycosylation, the recombinant protein migrates as an approximately 24 kD protein in SDS- PAGE under reducing conditions.\n\nEndotoxin Level: \n< 1.0 EU per 1 microg of the protein as determined by the LAL method.\n\nActivity: \nMeasured by its ability to bind biotinylated a-D-Mannose-PAA in a functional ELISA.\n\nReconstitution: \nIt is recommended that sterile PBS be added to the vial to prepare a working stock solution of no less than 100ug/ml. The carrier-free protein should be used immediately upon reconstitution to avoid losses in activity due to non-specific binding to the inside surface of the vial. For long term storage as a dilute solution, a carrier protein (e.g. 0.1% HSA or BSA) should be added to the vial.\n\nStorage and Stability: \nLyophilized samples are stable for up to twelve months at -20 degrees C. Upon reconstitution, this protein, in the presence of a carrier protein, can be stored under sterile conditions at 2-8 degrees C for one month or at -20 degrees C in a manual defrost freezer for three months without detectable loss of activity. Avoid repeated freeze-thaw cycles.

Prices direct from United States Biological

Quick response times

Exclusive Biosave savings/discounts

SPECIFICATIONS

Catalog Number

D1876-51

Size

50ug

Form

Supplied as a lyophilized powder in PBS.

Purity

(same/more than) 95%, as determined by SDS-PAGE and visualized by silver stain.

References

1. Kanazawa, N., 2007, J. Dermatol. Sci. 45:77. \n2. Kanazawa, N. et al., 2004, Immunobiology 209:179. \n3. Fernandes, M.J. et al., 1999, Cancer Res. 59:2709. \n4. Ariizumi, K. et al., 2000, J. Biol. Chem. 275:11957. \n5. Bonkobara, M. et al., 2005, Photochem. Photobiol. 81:944. \n6. Taylor, P.R. et al., 2005, Eur. J. Immunol. 35:2163. \n7. McGreal, E.P. et al., 2006, Glycobiology 16:422. \n8. Sato, K. et al., 2006, J. Biol. Chem. 281:38854. \n9. Aragane, Y. et al., 2003, J. Immunol. 171:3801.